Publications by authors named "Elizabeth A Kuczynski"

12Publications

Vessel co-option and resistance to anti-angiogenic therapy.

Angiogenesis 2020 02 21;23(1):55-74. Epub 2019 Dec 21.

Oncology R&D, AstraZeneca, Cambridge, UK.

View Article and Find Full Text PDF
February 2020

Vessel co-option in cancer.

Nat Rev Clin Oncol 2019 08;16(8):469-493

Tumour Biology Team, Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.

View Article and Find Full Text PDF
August 2019

Non-angiogenic tumours and their influence on cancer biology.

Nat Rev Cancer 2018 05 9;18(5):323-336. Epub 2018 Mar 9.

Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

View Article and Find Full Text PDF
May 2018

Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma.

Chin J Cancer 2016 Nov 25;35(1):97. Epub 2016 Nov 25.

Sunnybrook Research Institute, 2075 Bayview Avenue, S-Wing, Room S217, Toronto, ON, M4N 3M5, Canada.

View Article and Find Full Text PDF
November 2016

Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma.

J Natl Cancer Inst 2016 08 8;108(8). Epub 2016 Apr 8.

Affiliations of authors: Department of Medical Biophysics, University of Toronto, Toronto, Canada (EAK, FSF, RSK); Physical Sciences Platform (MY, FSF) and Biological Sciences Platform (CRL, SM, RSK), Sunnybrook Research Institute, Toronto, Canada; Department of Biomedical Engineering, Technion - Israel Institute of Technology, Haifa, Israel (ABZ); Keenan Research Centre, St. Michael's Hospital, Toronto, Canada (HB, GMY); The Breast Cancer Now Toby Robins Research Centre, Mary-Jean Mitchell Green Building, The Institute of Cancer Research, London, UK (FD, PBV, ARR); Translational Cancer Research Unit, GZA Hospitals St. Augustinus, Antwerp, Belgium (PBV).

View Article and Find Full Text PDF
August 2016

Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma.

Cancer Res 2015 Jun 23;75(12):2510-9. Epub 2015 Apr 23.

Department of Medical Biophysics, University of Toronto, Toronto, Canada. Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Canada.

View Article and Find Full Text PDF
June 2015

Drug rechallenge and treatment beyond progression--implications for drug resistance.

Nat Rev Clin Oncol 2013 Oct 3;10(10):571-87. Epub 2013 Sep 3.

Department of Medical Biophysics, University of Toronto, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

View Article and Find Full Text PDF
October 2013

VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma.

Oncology 2011 6;81(2):126-34. Epub 2011 Oct 6.

Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ont., Canada.

View Article and Find Full Text PDF
December 2011